Drug Type siRNA |
Synonyms |
Target |
Mechanism C5 inhibitors(Complement C5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rare Diseases | Phase 2 | CN | - | |
Disorder of Complement | Phase 1 | CN | - | |
Hemoglobinuria, Paroxysmal | IND Approval | SE | 01 Oct 2024 |